Navigation Links
Stryker Announces Exclusive Collaboration With RegenLab
Date:7/8/2011

SAN DIEGO, July 8, 2011 /PRNewswire/ -- Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine meeting that it has entered into an exclusive collaboration with RegenLab SA to distribute Stryker's RegenKit-THT, a one-step system designed for the safe and rapid preparation of autologous platelet-rich plasma (A-PRP) from a small sample of blood at the patient's point of care.

A-PRP contains an increased concentration of platelets, while maintaining physiological levels of leukocytes (white blood cells).  When activated, platelets have been found to release growth factors which may participate in the healing process, and a multitude of proteins and bioactive factors critical to the healing process and the recruitment of cells.  Leukocytes are responsible primarily for defending the body against infection, but are also key players during the initial inflammation phase of tissue healing.

In comparison to competitive offerings, the A-PRP prepared using Stryker's RegenKit-THT provides the highest platelet recovery and viability(1), while its simplified single tube preparation, with a minimal eight minute centrifuge spin time and reduced number of steps, helps maximize efficiency in the office and O.R.

"The RegenKit-THT system is the result of 10 years of scientific research in tissue regeneration and is designed to provide an autologous and physiological solution to promote a biological environment for regenerative cells enrichment.  RegenLab is pleased to collaborate with Stryker, a leader in medical technologies and innovation, which will allow for the widespread distribution of our A-PRP technology," said Antoine Turzi, Founder and CEO of RegenLab SA.

"The addition of the RegenKit for PRP therapy to Stryker's Joint Preservation Biologics portfolio allows us to provide surgeons with this emerging therapy for orthopaedic applications.  We're pleased to collaborate with RegenLab on the distribution of this system," said Matt Moreau, Vice President & General Manager, Stryker Joint Preservation.

To see a demonstration of this product, please visit Stryker at booth #503 at AOSSM.

About Stryker OrthopaedicsStryker Orthopaedics is a division of the Stryker Corporation, one of the world's leading medical technology companies. Stryker Orthopaedics offers an extensive orthopaedic product portfolio including hip, knee and upper extremity reconstructive devices, bone cement, trauma implants, bone substitutes, joint preservation products and spine systems. For more information about Stryker Orthopaedics, visit: http://www.stryker.com/en-us/products/Orthopaedics/index.htm

About StrykerStryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

(1) Study Report – Regen™ THT Tube Performance Testing, USFDA 510(k) BK090048, May 2010, Data on file at RegenLab, Switzerland.

NL11-FB-CO-1532Contact:Jeanine GuilfoyleStryker Orthopaedics201-831-6277jeanine.guilfoyle@stryker.com
'/>"/>

SOURCE Stryker Orthopaedics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Launches VersiTomic G-Lok™
2. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
3. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
4. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
5. Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System
6. Stryker Declares a $0.18 Per Share Quarterly Dividend
7. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
8. Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010
9. Stryker Corporation Named One of FORTUNE Magazines 100 Best Companies to Work For
10. TriMed, Inc. Announces Licensing Agreement with Stryker
11. Stryker Increases Expected 2010 Results and Provides 2011 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... Calif. , May 23, 2017  Leaf ... most innovative medical devices for pressure ulcer prevention, ... the American Association of Critical Care Nurses, National ... May 22-25. The Leaf Patient Monitoring ... specifically for the hospital environment.  The system seamlessly ...
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/18/2017)... N.J. , May 17, 2017  Bayer announced ... oncology portfolio will be presented at the 53 rd ... Oncology (ASCO), taking place June 2-6 in ... presented at ASCO span prostate, colorectal, liver and thyroid ... analysis from the Phase II CHRONOS-1 trial of copanlisib ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... May 26, 2017 , ... A May 8 article on CBCNews ... or respiratory issues that are not responsive to antibiotics nevertheless obtain prescriptions for them. ... largely responsible for the problem both in Canada and the United States. Dr. Michael ...
(Date:5/27/2017)... , ... May 27, 2017 , ... In any business, ... of the talent of your dental team at presenting treatment, there will always be ... a lot of time and money on best practices when it comes to presenting ...
(Date:5/27/2017)... Rosa, CA (PRWEB) , ... May 27, 2017 , ... ... cause for concern, but a new study from the Osteoarthritis Initiative shows ... to developing knee osteoarthritis. Knowing this in advance may give doctors the opportunity to ...
(Date:5/26/2017)... ... May 26, 2017 , ... The ... to review more than eighty-nine grant submissions all vying for nearly $1,000,000 in ... the Parkinson’s field.     , The American Parkinson Disease Association (APDA) is focused on ...
(Date:5/26/2017)... ... 26, 2017 , ... The Radiology Business Management Association ... current legislative activity and the latest regulatory concerns impacting RBMA members. The Legislative ... and will continue through Monday, Sept. 11, at the Ritz-Carlton, Tysons Corner in ...
Breaking Medicine News(10 mins):